Currently, the medical sector has a major information management problem. This has been caused by the increase in knowledge in its scope, but also in the level of detail. The consequences are delays in the transfer of research results to effective therapies and massive cost increases due to increased expenditure. The medical sector definitely needs a solution. Our Startup of the Week, Healex, has developed an exciting platform approach that can help many stakeholders in the healthcare sector. We met Christoph Plamper from Healex for an interview.
Hello Christoph! Thank you for taking time for us today. Please explain shortly what Healex is.
Healex is a software and consulting company based in Cologne and Berlin that develops products and solutions for the efficient planning, control and acceleration of clinical trials, for therapy consulting in patient care and for the management of large volumes of clinical and health data.
You have developed your own platform for this, right? What is the goal of the platform?
Yes, exactly. The “Healex Site Management System” (SMS) brings together sponsors, researchers and investigators on an innovative platform and enables the planning, implementation and collaboration in clinical studies across multiple sites. Clinical studies are thus significantly accelerated and digitally managed. By supporting international medical data standards such as “FHIR” and the “Healex Clinical Hub”, a FHIR-based platform for structured clinical data, the “Healex Site Management System” (SMS) and our other solutions can be seamlessly integrated into existing hospital systems and research infrastructures, enabling the easy integration and use of structured clinical data for research and care.
What is special about this approach?
We bring together sponsors from pharma, clinics, research networks, researchers and investigators on our platforms. With the platforms we provide powerful collaboration tools and solutions for structuring clinical data. Both ensure that personalised therapies can be developed faster. In addition they are more data-driven and thus more cost-effectively in the long term.
Do you only sell your Healex Site Management System?
No. We develop and sell IT solutions in the B2B healthcare market, mainly our own but also partner solutions. This happens usually through multi-year license agreements, both SaaS and on-premise. We focus on platform models as well as product families and individual products. Roughly, we have divided our product and business model into two levels: Our core products are primarily aimed at large hospitals, pharmaceuticals and research organizations and are networked infrastructure solutions. Our Corona web tools are flexible web solutions that many industries can use. The core of our business model is that you can use almost all our solutions independently but also connect them and use them together. Business model is 70% product sales and development and approx. 30% consulting. We do not offer any other services apart from our core products.
Who falls within your target group?
Our target groups are mainly large university hospitals and research networks. Many hospitals, pharmaceutical companies and health insurance companies are customers as well.
What are your successes that you like to look back on?
For more than twelve years we have been supporting research groups and physicians in the integration of clinical care and research. Due to our close cooperation with one of the largest university hospitals in Germany, we have deep experience and proven solutions to critical processes and problems in clinical research and care. For many of these challenges, we have already delivered solutions that thousands of researchers and physicians use every day in numerous multinational clinical trials.